RQ20 is the new major research quality evaluation at Lund University, based on self-evaluations and will involve around 5 000 members of staff.

RQ20 is tasked with providing a picture of how competitive the research of Lund University is in an international context. Above all, the evaluation is to look to the future by identifying strengths, weaknesses and development potential in all of the University´s different research environments and to produce advisory documentation for the future.

The evaluation is based on connected research environments (Units of Assessment). These are defined as subjects, in some cases as departments or divisions, and in others as larger research groups or research themes.

35 large Panels will be defined at Lund university each containing 4-8 Units of Assessment with external evaluator linked to each Panel. The Faculty of Medicine is divided in 9 Panels and 52 Units of Assessment.

Panels and units of assessment at the Faculty of Medicine

Panel 1: Neuroscience, chairman Angela Cenci-Nilsson

Units of Assessments:

• 1A: Neurobiology and cell therapy, chairman Malin Parmar
• 1B: Neurophysiology and neuronanomedicine, chairman Jens Schouenborg

• 1C: Basal ganglia disease models, chairman Angela Cenci-Nilsson

• 1D: Neurodegeneration, epilepsy, experimental therapeutics, chairman Christian Hansen

• 1E: Dementia research, chairman Oscar Hansson

• 1F: Neurology and clinical neurogenetics, chairman Per Odin

Panel 2: Cancer, basic, tranlational, chairman Lars Rönnstrand

Units of Assessments:

• 2A: Clinical Genetics, chairman Fredrik Mertens 
• 2B: Hematology and transfusion medicine, chairman Björn Nilsson 
• 2D: Translational Cancer Research I, chairman Daniel Bexell 
• 2E: Translational Cancer Research II, chairman Maria Alvarado-Kristensson, Yvonne Giwercman 

Panel 3: Cancer, clinical, chairman Mats Jerkeman

Units of Assessments:

• 3A: Cancer research - clinical, basic, chairman Bo Baldetorp 
• 3B: Cancer research - experimental, chairman Lao Saal 
• 3C: Tumor pathology, chairman Karin Jirström 
• 3D: Cancer research - abdominal, urological, chairman Anders Bjartell 

Panel 4: Regenerative medicine, chairman Jonas Larsson/Mikael Sigvardsson

Units of Assessments:

• 4A: Molecular Medicine and Gene Therapy, chairman Jonas Larsson 
• 4B: Molecular Hematology, chairman Mikael Sigvardsson 

Panel 5: Blood and defense, chairman Anders P Håkansson

Units of Assessments:

• 5A: Clinical/molecular infection medicine, chairman Bo Åkerström 
• 5B: Immunology, chairman William Agace 
• 5C: Transfusion and hemostasis, chairman John Semple 
• 5D: Clinical and experimental autoimmunity, chairman Anders Bengtsson 
• 5E: Clinical chemistry, chairman Magnus Abrahamsson 
• 5F: Virology, chairman Marianne Jansson 
• 5G: Clinical and experimental microbiology, chairman Catharina Svanborg 
• 5H: Protein chemistry, chairman Anna Blom 

Panel 6: Metabolic and cardiovascular research, chairman Lena Eliasson

Units of Assessments:

• 6A: Diabetes and insulin action, chairman Jens Lagerstedt 
• 6B: Cardiovascular research, chairman Maria Gomez 
• 6C: Diabetes and defect islet function, chairman Lena Eliasson 
• 6D: Diabetes genetics and epidemiology, chairman Paul Franks 
• 6E: Type 1 diabetes, chairman Åke Lernmark

Panel 7: Sustainable health, chairman Susanne Iwarsson

Units of Assessments:

• 7A: Occupational and Environmental Medicine, chairman Lars Rylander 
• 7B: Global Health, chairman Inger Hallström
• 7C: Older People, Ageing and Health, chairman Susanne Iwarsson 
• 7D: EpiHealth, Registers, Epidemiology, chairman Peter Nilsson 
• 7E: Community Medicine, chairman Martin Lindström 
• 7F: Activity, participation, mental health, chairman Ulrika Bejerholm 
• 7G: Rehabilitation medicine, Physiotherapy, Sports science, Health promotion, chairman  Jan Lexell 
• 7H: Emergency and high-technological environments, chairman Anna Forsberg/Pia Lundqvist 

Panel 8: Tissue, cell and molecular biology and medical techniques, chairman Bengt-Olof Nilsson

Units of Assessments:

• 8A: Airway biology, chairman Cecilia Andersson 
• 8B: Vascular physiology, chairman Bengt-Olof Nilsson 
• 8C: Pharmacology and Structure biology, chairman Fredrik Leeb-Lundberg
• 8D: Cell and molecular biology, chairman Anders Aspberg 

Panel 9: Highly specialized clinical research, chairman Stefan Lindgren

Units of Assessments:

• 9A: Gastrointestinal research, chairman Stefan Lindgren 
• 9B: Heart- Lung Research, chairman David Erlinge 
• 9C: Orthopedics and hand surgery, chairman Magnus Karlsson 
• 9D: Audiology, speech-language-pathology, phoniatrics, ENT, chairman Jonas Brännström 
• 9E: Psychiatry, Medical ethics, Medical history, chairman Åsa Westrin 
• 9F: Surgery, chairman Niklas Marklund 
• 9G: Medical imaging, physiology and radiation physics, chairman Lars E Olsson 
• 9H: Paediatrics, Reproduction, Gynaecology and Obstetrics, chairman Rolf Ljung 
• 9I: Eye and ear-nose-throat research, chairman Boel Bengtsson 
• 9J: Dermatology and Venereology, chairman Artur Schmidtchen 
• 9K: Medical Radiation Physics, chairman Michael Ljungberg